Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

Celgene

BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer

BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer

However, BMS is likely hoping that its upcoming $74bn takeover of Celgene will reduce its reliance on Opdivo in its top-line.

Evotec and Vifor announce joint venture for kidney disease treatments

Evotec and Vifor announce joint venture for kidney disease treatments Evotec’s proprietary PanHunter bioinformatics drug discovery platform has already attracted a number of deals with big pharma  Novo Nordisk,   Sanofi and Celgene, among others.

BMS’ Opdivo stalls in Q3, but overall figures still top expectations

BMS’ Opdivo stalls in Q3, but overall figures still top expectations Regardless, BMS group sales rose 6% to $6bn in the quarter – around $100m more than consensus forecasts – as it prepares for its $74bn takeover of Celgene that will dilute Opdivo’s ... Caforio also pointed to Celgene’s strong results, which were

NICE turns down Roche’s Tecentriq for triple-negative breast cancer

NICE turns down Roche’s Tecentriq for triple-negative breast cancer Tecentriq has been approved by the EMA for use in patients ineligible for surgery alongside Celgene’s Abraxane (nab-paclitaxel), and NICE estimates that around 600 of the 2, 000 women

European biotech: a new generation of leaders emerges

European biotech: a new generation of leaders emerges The phase 2 L-MIND study in diffuse large B-cell lymphoma (DLBCL) showed the combination of tafasitamab with Celgene’s Revlimid (lenalidomide) had an overall response rate of 60%, with

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics